Figure 3.
Change in DAS28 According to Initial Strategy and Subsequent Treatment
Mean scores according to the therapies received during the course of the 48-week intervention period. Both groups of participants who switched therapies at 24 weeks (27% for each group) had significant improvement after the switch (P < .001 for each group), with no significant difference in the amount of improvement. Reprinted with permission of the Massachusetts Medical Society, copyright 2013.4
Abbreviation: DAS28, disease activity score.